Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

5-HTTLPR and BDNF Val66Met polymorphisms and response to rTMS treatment in drug resistant depression.

Neuroscience letters - 30 May 2008

Bocchio-Chiavetto Luisella, Miniussi Carlo, Zanardini Roberta, Gazzoli Anna, Bignotti Stefano, Specchia Claudia, Gennarelli Massimo

Abstract excerpt

Repetitive transcranial magnetic stimulation (rTMS) is a painless and safe brain stimulation technique that has been found to be effective in treating depression symptoms. The potential usefulness of rTMS, in particular to treat drug resistant patients, might be increased by identifying genetic predictors of efficacy. According to this rationale, we investigated the role of two functional polymorphisms in the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Polymorphism, Genetic
Share to Aged

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antidepressive Agents

Share to Brain-Derived Neurotrophic Factor

Share to Depressive Disorder

Share to Drug Resistance

Share to Serotonin Plasma Membrane Transport Proteins

Share to Transcranial Magnetic Stimulation

Source

Identifiers

PMID: 18450378
DOI: 10.1016/j.neulet.2008.04.005

Genes

BDNF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

5-HTTLPR and BDNF Val66Met polymorphisms and response to rTMS treatment in drug resistant depression.PMID 18450378Read ↗

Impact of 5-HTTLPR and BDNF polymorphisms on response to sertraline versus transcranial direct current stimulation: implications for the serotonergic system.Semantic proximity Read ↗

The association of brain-derived neurotrophic factor with the diagnosis and treatment response in depression.Semantic proximity Read ↗

Serotonin transporter gene polymorphisms and treatment-resistant depression.Semantic proximity Read ↗

Serum brain-derived neurotrophic factor, Val66Met polymorphism and open-label SSRI treatment response in Major Depressive Disorder.Semantic proximity Read ↗

Role of COMT, 5-HT(1A) , and SERT genetic polymorphisms on antidepressant response to Transcranial Magnetic Stimulation.Semantic proximity Read ↗

Serotonin transporter gene polymorphisms and sertraline response in major depression patients.Semantic proximity Read ↗

Interaction between 5-HT1A and BDNF genotypes increases the risk of treatment-resistant depression.Semantic proximity Read ↗

Association of serum BDNF level and Val66Met polymorphism with response to treatment in patients of major depressive disease: A step towards personalized therapy.Semantic proximity Read ↗

Low-frequency repetitive transcranial magnetic stimulation in the right prefrontal cortex combined with partial sleep deprivation in treatment-resistant depression: a randomized sham-controlled trial.Semantic proximity Read ↗

Meta-analysis of BDNF Val66Met polymorphism association with treatment response in patients with major depressive disorder.Semantic proximity Read ↗

Genetic Role of BDNF Val66Met and 5-HTTLPR Polymorphisms on Depressive DisorderSemantic proximity Read ↗

Serotonin transporter 5-HTTLPR polymorphism and escitalopram treatment response in patients with major depressive disorder.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.